Patients with sickle cell disease (SCD) and osteoporosis experience stable bone mineral density (BMD) upon being administered alendronate, according to a study published in Osteoporosis International. SCD can cause a multitude of complications, including those of a skeletal nature; these are collectively termed “sickle bone disease.” Up to 8 in...